(Q57061755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

title

Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Barbara M Rainer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

15

Stefan Pilz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

author name string

Christoph Hoeller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Martin Wolf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Ingrid Wolf

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Günter Schulter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Markus Richtig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Martin R Grübler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Anna Gappmayer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Thomas Haidn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Julian Kofler

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Rainer Huegel

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Bernhard Lange-Asschenfeldt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Martin Pichler

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Akos Heinemann

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

Erika Richtig

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

language of work or name

English

0 references

publication date

1 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

page(s)

e0204729

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

25 April 2020

copyright license

start time

1 October 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies

1 reference

12 December 2020

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

12 December 2020

Final version of 2009 AJCC melanoma staging and classification

1 reference

12 December 2020

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

1 reference

12 December 2020

Immunological complications of obesity

1 reference

12 December 2020

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

1 reference

12 December 2020

Nivolumab plus ipilimumab in advanced melanoma

1 reference

12 December 2020

Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis

1 reference

12 December 2020

Role of obesity on the thickness of primary cutaneous melanoma

1 reference

12 December 2020

American Society of Clinical Oncology position statement on obesity and cancer

1 reference

12 December 2020

Obesity and cancer immunotherapy toxicity

1 reference

12 December 2020

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

1 reference

12 December 2020

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

1 reference

12 December 2020

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

1 reference

12 December 2020

IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?

1 reference

12 December 2020

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

1 reference

12 December 2020

Overweight and obesity predict better overall survival rates in cancer patients with distant metastases

1 reference

12 December 2020

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

1 reference

12 December 2020

Obesity accelerates T cell senescence in murine visceral adipose tissue

1 reference

12 December 2020

The Human Intestinal Microbiome in Health and Disease

1 reference

12 December 2020

The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma

1 reference

12 December 2020

Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment.

1 reference

12 December 2020

Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response - One Size Fits Not All.

1 reference

12 December 2020

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

1 reference

12 December 2020

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0204729

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30273398%20AND%20SRC:MED&resulttype=core&format=json

25 April 2020

1 reference